SCHEMBL25979762

SCHEMBL25979762

c1ccc(-c2ccc(N(c3ccc(-c4ccccc4)cc3)c3cccc(-c4ccc5c(c4)oc4cc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)ccc45)c3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.36
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
HPGD P15428 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
GAA P10253 2/20 0.35
KDM4E B2RXH2 4/20 0.35
LMNA P02545 2/20 0.35
GLA P06280 2/20 0.35
HCRTR1 O43613 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
PDE5A O76074 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26779232 1.00 MAPT (0.36) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL25979758 1.00 MAPT (0.36) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL26779202 0.99 MAPT (0.35) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL25979480 0.99 MAPT (0.35) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL26779203 0.97 MEN1 (0.36) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL25979738 0.97 MEN1 (0.37) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL25979908 0.96 MAPT (0.35) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL25979803 0.96 MAPT (0.35) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL25979907 0.96 MAPT (0.36) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL25979639 0.96 MEN1 (0.38) MAPTALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MAPT 1428/4885ALDH1A1 9/4885MEN1 257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.